Cai Yantao, Ge Ying, Ung Carolina Oi Lam, Li Fuli, Wang Jiaqi, Xia Chenglai, Hu Hao
Affiliated Foshan Maternity & Child Healthcare Hospital, Southern Medical University, Foshan, China.
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao SAR, China.
SAGE Open Med. 2021 Nov 23;9:20503121211056844. doi: 10.1177/20503121211056844. eCollection 2021.
This study aimed to make use of real-world medical records to explore the clinical characteristics, treatments, and outcomes of infantile hemangiomas in southeastern China.
This study applied a retrospective observational method using real-world data derived from the electronic medical records of the Foshan Women and Children Hospital, southeastern China dated between June 2014 and June 2019.
A total of 2427 patients with infantile hemangiomas were recruited in this study, including 942 (38.8%) males and 1485 (61.2%) females. Among the participants, 620 (25.5%) were high-risk infantile hemangioma, 449 (18.5%) were medium risk, and 1358 (56.0%) were low risk. A total of 14 treatment patterns in clinical practice were identified. The top 3 treatment patterns in each group of risk levels were the same: laser therapy, a combination of laser therapy and topical timolol maleate, and topical timolol maleate. The outcomes of the top 3 treatment patterns were significantly ( < 0.05) different in each risk group.
Among the top 3 treatment patterns, laser therapy or a combination of laser therapy and topical timolol maleate were more likely to have an "Excellent" outcome.
本研究旨在利用真实世界的医疗记录,探讨中国东南部婴幼儿血管瘤的临床特征、治疗方法及治疗效果。
本研究采用回顾性观察方法,使用来自中国东南部佛山市妇幼保健院2014年6月至2019年6月电子病历中的真实世界数据。
本研究共纳入2427例婴幼儿血管瘤患者,其中男性942例(38.8%),女性1485例(61.2%)。参与者中,620例(25.5%)为高危婴幼儿血管瘤,449例(18.5%)为中危,1358例(56.0%)为低危。临床实践中确定了14种治疗模式。各风险水平组中排名前3的治疗模式相同:激光治疗、激光治疗与局部马来酸噻吗洛尔联合治疗、局部马来酸噻吗洛尔。各风险组中排名前3的治疗模式的治疗效果存在显著差异(<0.05)。
在排名前3的治疗模式中,激光治疗或激光治疗与局部马来酸噻吗洛尔联合治疗更有可能获得“优”的治疗效果。